Search - tctmd.com

Displaying 441 - 460 of 916

Sort: Relevancy | Date

Presentation TCT 2018

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Presenter: Antonio Colombo, Jeffrey W. Moses, Stuart J. Head

September 22, 2018

Presentation TCT 2018

Defining What Constitutes a Clinically Relevant Peri-Procedural MI: Analysis in > 17,000 Patients

Presenter: Antonio Colombo, Jeffrey W. Moses, Jung-Min Ahn

September 22, 2018

Presentation TCT 2018

TCT-8: Fate Of Deferred Lesions Using State-Of-Art Percutaneous Coronary Revascularization In Patients With De Novo Three Vessel Disease: Lesion Level Analysis At 2 Years Of The SYNTAX II Study

Presenter: Steven R. Bailey, Patrick W. Serruys, Norihiro Kogame

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

Presentation TCT 2018

Three-year Outcomes of Surgical Vs. Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study

Presenter: Osamu Iida, Shigeru Saito

September 21, 2018

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

Presentation TCT 2018

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

Presenter: John D. Puskas, Alfredo Trento, Craig Basman

September 21, 2018

Presentation TCT 2018

TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice

Presenter: John D. Puskas, Alfredo Trento, Choongki Kim

September 21, 2018

Presentation TCT 2018

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, R. Jay Widmer

September 21, 2018

Presentation TCT 2018

TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries

Presenter: Allen Jeremias, Hernan Mejia-Renteria

September 21, 2018

Presentation TCT 2018

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Presenter: Nicholas J. Lembo, Marie-Claude Morice, Gennaro Giustino

September 21, 2018

Presentation TCT 2018

Revascularization in Cardiogenic Shock: New Insights

Presenter: Jeroen J. Bax, Stephan Windecker, Holger Thiele

September 21, 2018

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

Presentation ESC 2018

2018 ESC/EACTS Guidelines on Myocardial Revascularization

Presenter: Franz-Josef Neumann

August 30, 2018

Presentation ESC 2018

FUnctional Testing Underlying REvascularization The FUTURE trial

Presenter: Gilles Rioufol

August 26, 2018

Presentation The Structural Heart Disease Summit 2018

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

Presenter: Torsten P. Vahl

June 21, 2018

Presentation SCAI 2018

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

Presenter: Andrew McNeice

April 28, 2018

Presentation SCAI 2018

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

Presenter: David E. Kandzari

April 28, 2018

Presentation

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

April 23, 2018

Advertisement

Mortality and Stroke Outcomes of PCI vs CABG in MVD and LMD With and Without Diabetes

Defining What Constitutes a Clinically Relevant Peri-Procedural MI: Analysis in > 17,000 Patients

TCT-8: Fate Of Deferred Lesions Using State-Of-Art Percutaneous Coronary Revascularization In Patients With De Novo Three Vessel Disease: Lesion Level Analysis At 2 Years Of The SYNTAX II Study

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Three-year Outcomes of Surgical Vs. Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

TCT-108: Long-term Survival After Hybrid Coronary Revascularization for Triple-Vessel Disease: How Does it Compare to Coronary Artery Bypass Surgery or Multi-Vessel Percutaneous Intervention?

TCT-107: Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multi-Vessel Coronary Artery Disease in Real-World Practice

TCT-36: The Impact of Guideline-Directed Medical Therapy after Revascularization in Patients With Left Main Coronary Artery Disease: Analysis From the EXCEL Trial

TCT-11: Assessment of the Adenosine-Dependent Hyperemic Response During the Subacute Phase of a Myocardial Infarction: Insights for FFR-Guided Coronary Revascularization in Non-Infarcted-Related Arteries

TCT-33: Mortality After Repeat Revascularization Following PCI or CABG for Left Main Coronary Artery Disease: The EXCEL Trial

Revascularization in Cardiogenic Shock: New Insights

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

2018 ESC/EACTS Guidelines on Myocardial Revascularization

FUnctional Testing Underlying REvascularization The FUTURE trial

Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization)

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

Hybrid Coronary Revascularization (HRC) in Selected Patients With Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content